The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Proatherogenic Role of Elevated CE Transfer From HDL to VLDL 1 and Dense LDL in Type 2 Diabetes: Impact of the Degree of Triglyceridemia
Open accessAbstract
Abstract —Plasma cholesteryl ester transfer protein (CETP) facilitates intravascular lipoprotein remodeling by promoting the heteroexchange of neutral lipids. To determine whether the degree of triglyceridemia may influence the CETP-mediated redistribution of HDL CE between atherogenic plasma lipoprotein particles in type 2 diabetes, we evaluated CE mass transfer from HDL to apoB-containing lipoprotein acceptors in the plasma of type 2 diabetes subjects (n=38). In parallel, we investigated the potential relationship between CE transfer and the appearance of an atherogenic dense LDL profile. The diabetic population was divided into 3 subgroups according to fasting plasma triglyceride (TG) levels: group 1 (G1), TG<100 mg/dL; group 2 (G2), 100<TG<200 mg/dL; and group 3 (G3), TG>200 mg/dL. Type 2 diabetes patients displayed an asymmetrical LDL profile in which the dense LDL subfractions predominated. Plasma levels of dense LDL subfractions were strongly positively correlated with those of plasma triglyceride (TG) ( r =0.471; P =0.0003). The rate of CE mass transfer from HDL to apoB-containing lipoproteins was significantly enhanced in G3 compared with G2 or G1 (46.2±8.1, 33.6±5.3, and 28.2±2.7 μg CE transferred · h −1 · mL −1 in G3, G2, and G1, respectively; P <0.0001 G3 versus G1, P =0.0001 G2 versus G1, and P =0.02 G2 versus G3). The relative capacities of VLDL and LDL to act as acceptors of CE from HDL were distinct between type 2 diabetes subgroups. LDL particles represented the preferential CE acceptor in G1 and accounted for 74% of total CE transferred from HDL. By contrast, in G2 and G3, TG-rich lipoprotein subfractions accounted for 47% and 72% of total CE transferred from HDL, respectively. Moreover, the relative proportion of CE transferred from HDL to VLDL 1 in type 2 diabetes patients increased progressively with increase in plasma TG levels. The VLDL 1 subfraction accounted for 34%, 43%, and 52% of total CE transferred from HDL to TG-rich lipoproteins in patients from G1, G2, and G3, respectively. Finally, dense LDL acquired an average of 45% of total CE transferred from HDL to LDL in type 2 diabetes patients. In conclusion, CETP contributes significantly to the formation of small dense LDL particles in type 2 diabetes by a preferential CE transfer from HDL to small dense LDL, as well as through an indirect mechanism involving an enhanced CE transfer from HDL to VLDL 1 , the specific precursors of small dense LDL particles in plasma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapman, M. J., Goldstein, S., Lagrange, D., & Laplaud, P. M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35376-1 · Cited by 553
Self-citationLipoprotein Heterogeneity and Apolipoprotein B Metabolism
Packard, C. J., & Shepherd, J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.12.3542 · Cited by 402
An overview of reverse cholesterol transport.
Tall, A. R. (1998) · PubMed · Cited by 248
Guerin, M., Lassel, T. S., Le Goff, W., Farnier, M., & Chapman, M. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.1.189 · Cited by 237
Self-citationMcPherson, R., Mann, C. J., Tall, A. R., Hogue, M., Martin, L., Milne, R. W., & Marcel, Y. L. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.797 · Cited by 215
DULLAART, R. P. F., SLUITER, W. J., DIKKESCHEI, L. D., HOOGENBERG, K., & TOL, A. V. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb00987.x · Cited by 195
Speijer, H., Groener, J. E. M., VANRAMSHORST, E., & Vantol, A. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90110-o · Cited by 149
Self-citationRiemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00111-7 · Cited by 140
Fielding, C. J., Reaven, G. M., Liu, G., et al. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2512 · Cited by 136
de Man, F. H. A. F., Cabezas, M. C., van Barlingen, H. H. J. J., Erkelens, D. W., & de Bruin, T. W. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.114256.x · Cited by 124
Cited by
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationNew Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,093
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Diabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 870
Self-citationWu, L., & Parhofer, K. G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.08.010 · Cited by 516
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Parhofer, K. G. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.5.353 · Cited by 458
Dobiášová, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.033175 · Cited by 419
Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
Self-citationDietary, physiological, genetic and pathological influences on postprandial lipid metabolism
Lopez-Miranda, J., Williams, C., & Lairon, D. (2007) · British Journal of Nutrition · doi:10.1017/s000711450774268x · Cited by 320
Boekholdt, S. M., Sacks, F. M., Jukema, J. W., Shepherd, J., Freeman, D. J., McMahon, A. D., Cambien, F., Nicaud, V., de Grooth, G. J., Talmud, P. J., et al. (2005) · Circulation · doi:10.1161/01.cir.0000153341.46271.40 · Cited by 308
Chapman, M. J., Le Goff, W., Guerin, M., & Kontush, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp399 · Cited by 298
Self-citationBorggreve, S. E., De Vries, R., & Dullaart, R. P. F. (2003) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2003.01263.x · Cited by 278
Rashid, S., Watanabe, T., Sakaue, T., & Lewis, G. F. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00078-x · Cited by 277
Chapman, M. J., Assmann, G., Fruchart, J.-C., Shepherd, J., & Sirtori, C. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004402 · Cited by 257
Self-citationLow-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
Sacks, F. M., & Campos, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030636 · Cited by 241
Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201
Self-citation
Metadata
- Authors
- Guérin, M., Le Goff, W., Lassel, T. S., Van Tol, A., Steiner, G., & Chapman, M. J.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2001-02
- Volume
- 21
- Issue
- 2
- Pages
- 282-288
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2069610898
- Cited by
- 258
- References
- 27
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.